Construction project managers are always looking for methods for forecasting future projects and preventing of potential delays in the project. One of the most crucial requirements of construction project managers and financial planners is awareness of project cash flow and financial status. On the other hand, the unique properties of construction projects with uncertainties such as activity duration, the variability of resources, material costs and also ambiguity in the employer’s payments are factors that have an effect on the correct prediction of project cash flow. Hence, the project team should examine project cash flow under uncertainty environment. There are many approaches for considering uncertainty such as fuzzy sets, interval theory, rough and grey system. But the most well-known approach is fuzzy sets which has wide applications in engineering and management. Hence in this paper, we proposed a new method for forecasting project cash flow under fuzzy environment. Finally, the proposed method was applied on an “Engineering, Procurement and Construction” (EPC) project and it is demonstrated that the proposed model has a high performance in the prediction of project cash flow.
Primary immunodeficiency disease (PID) comprises a genetically heterogeneous group of disorders caused by defects in components of the immune system. PIDs affect different components of the innate and adaptive immune systems, including neutrophils, macrophages, dendritic cells, complement proteins, natural killer (NK) cells, and T-and B-lymphocytes. [1 2] This open-access article is distributed under Creative Commons licence CC-BY-NC 4.0.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.